Seven-transmembrane receptors, also known as G-protein-coupled receptors (GPCRs), are integral membrane proteins that contain seven membrane-spanning helices. This superfamily of cell surface signaling proteins plays a critical role in many physiological processes and diseases, including cancer. GPCRs and GPCR-related proteins upstream (e.g., ligands) and downstream (e.g., phosphodiesterase [PDEs] for cAMP degradation) from GPCRs account for approximately 17% of all protein targets for approved drugs. Thus, GPCRs are one of the most popular drug targets today. Almost one-third of the currently approved drugs rely on some kind of interaction with these receptors. Approved drugs targeting GPCRs and GPCR-related proteins are primarily small molecules and peptides. In the future, the number of GPCR targets, GPCR-based drugs and the types of drugs will continuously increase since approximately 100 of more than 360 human endogenous GPCRs are orphan GPCRs.
BOC Sciences has established a high-quality library of small GPCR compounds to screen for GPCRs with unknown function, yielding potential novel GPCR candidates.
Figure 1. Dynamics of the G-protein in the mechanism of activation of a GPCR. (Martins, S.; et al. 2012)
Given the importance of GPCR in small-molecule drug discovery, BOC Sciences offers a range of potential GPCR activity modulators. Our teams apply ligand-based (computational chemistry, 2D fingerprint similarity search) and receptor-based (molecular docking, high-throughput virtual screening) methods to select GPCR-focused screening compounds.
BOC Sciences provides professional, rapid and high-quality services of GPCR Screening Library design at competitive prices for global customers. Personalized and customized services of GPCR Screening Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.